Status:
COMPLETED
Fish Oil T Cell Function
Lead Sponsor:
Texas A&M University
Conditions:
Muscle Strength
Cognitive Function
Eligibility:
All Genders
55+ years
Phase:
NA
Brief Summary
The purpose of the study is to examine the effect of dietary n-3 polyunsaturated fatty acid supplementation on subjects' pan CD4+ T cell function, cognition, and muscle function. Half of the participa...
Detailed Description
Generalized inflammation has been consistently associated with aging and metabolic diseases, often characterized by reduced muscle and cognitive function. Although much of the aging-associated inflamm...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Healthy male or female according to the investigator/appointed staff judgment
- 55 years and older
- Stable body weight for the past 3 months (\< 5% change)
- Exclusion criteria:
- History of cardiovascular disease
- Metabolic diseases, including hepatic or renal disorders
- Presence of acute illness or metabolically unstable chronic illness (including diagnosis of Insulin Dependent Diabetes Mellitus)
- Unwilling to stop taking nutritional supplements containing proteins or free amino acids within 5 days of the first study day until study completion
- Participated in a nutritional supplement study program within the past 4 weeks
- Any other condition according to the PI or nurse that would interfere with the study or safety of the subject or influence the results
- Daily use of supplements containing \> 1000 mg EPA+DHA 3 months prior to the first test day
- Known hypersensitivity to fish and/or shellfish, Swanson EFAs Super EPA Fish oil or any of its ingredients, Swanson EFAs Certified Organic Extra Virgin Olive oil or any of its ingredients
- Presence of fever within the last 3 days
- Failure to give informed consent
- (Possible) Pregnancy
- Unwilling to comply with any other rules set forth in the Informed Consent Form
Exclusion
Key Trial Info
Start Date :
January 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2019
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT02775084
Start Date
January 1 2016
End Date
April 1 2019
Last Update
April 22 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Texas A&M University-CTRAL
College Station, Texas, United States, 77843